{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:54:38Z","timestamp":1791910478359,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims\/hypothesis<\/jats:title>\n                    <jats:p>\n                      Wolfram syndrome is a rare autosomal recessive disorder caused by pathogenic variants in the\n                      <jats:italic>WFS1<\/jats:italic>\n                      gene. It is characterised by insulin-dependent diabetes mellitus, optic nerve atrophy, diabetes insipidus, hearing loss and neurodegeneration. Considering the unmet treatment need for this orphan disease, this study aimed to evaluate the therapeutic potential of glucagon-like peptide 1 receptor (GLP-1R) agonists under wolframin (WFS1) deficiency with a particular focus on human beta cells and neurons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The effect of the GLP-1R agonists dulaglutide and exenatide was examined in\n                      <jats:italic>Wfs1<\/jats:italic>\n                      knockout mice and in an array of human preclinical models of Wolfram syndrome, including WFS1-deficient human beta cells, human induced pluripotent stem cell (iPSC)-derived beta-like cells and neurons from control individuals and individuals affected by Wolfram syndrome\n                      <jats:italic>,<\/jats:italic>\n                      and humanised mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study shows that the long-lasting GLP-1R agonist dulaglutide reverses impaired glucose tolerance in WFS1-deficient mice, and that exenatide and dulaglutide improve beta cell function and prevent apoptosis in different human WFS1-deficient models including iPSC-derived beta cells from people with Wolfram syndrome. Exenatide improved mitochondrial function, reduced oxidative stress and prevented apoptosis in Wolfram syndrome iPSC-derived neural precursors and cerebellar neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>Our study provides novel evidence for the beneficial effect of GLP-1R agonists on WFS1-deficient human pancreatic beta cells and neurons, suggesting that these drugs may be considered as a treatment for individuals with Wolfram syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-023-05905-8","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:06:50Z","timestamp":1680160010000},"page":"1306-1321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models"],"prefix":"10.1007","volume":"66","author":[{"given":"Vyron","family":"Gorgogietas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Rajaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae","family":"Heeyoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Santacreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mar\u00edn-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Salpea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Sawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyishai","family":"Musuaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda N.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moreno-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Benabdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Demarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pachera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lytrivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Carnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Urano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio L.","family":"Eizirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cnop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Igoillo-Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"issue":"3","key":"5905_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmg.14.3.190","volume":"14","author":"FC Fraser","year":"1977","unstructured":"Fraser FC, Gunn T (1977) Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome? J Med Genet 14(3):190\u2013193. https:\/\/doi.org\/10.1136\/jmg.14.3.190","journal-title":"J Med Genet"},{"issue":"8988","key":"5905_CR2","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/s0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346(8988):1458\u20131463. https:\/\/doi.org\/10.1016\/s0140-6736(95)92473-6","journal-title":"Lancet"},{"issue":"2","key":"5905_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","volume":"20","author":"H Inoue","year":"1998","unstructured":"Inoue H, Tanizawa Y, Wasson J et al (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20(2):143\u2013148. https:\/\/doi.org\/10.1038\/2441","journal-title":"Nat Genet"},{"issue":"2","key":"5905_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/hmg\/ddm296","volume":"17","author":"M Zatyka","year":"2008","unstructured":"Zatyka M, Ricketts C, da Silva Xavier G et al (2008) Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress. Hum Mol Genet 17(2):190\u2013200. https:\/\/doi.org\/10.1093\/hmg\/ddm296","journal-title":"Hum Mol Genet"},{"key":"5905_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1750-1172-7-92","volume":"7","author":"KA Pickett","year":"2012","unstructured":"Pickett KA, Duncan RP, Hoekel J et al (2012) Early presentation of gait impairment in Wolfram syndrome. Orphanet J Rare Dis 7:92. https:\/\/doi.org\/10.1186\/1750-1172-7-92","journal-title":"Orphanet J Rare Dis"},{"issue":"47","key":"5905_CR6","doi-asserted-by":"publisher","first-page":"39609","DOI":"10.1074\/jbc.M507426200","volume":"280","author":"SG Fonseca","year":"2005","unstructured":"Fonseca SG, Fukuma M, Lipson KL et al (2005) WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic \u03b2-cells. J Biol Chem 280(47):39609\u201339615. https:\/\/doi.org\/10.1074\/jbc.M507426200","journal-title":"J Biol Chem"},{"issue":"3","key":"5905_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","volume":"120","author":"SG Fonseca","year":"2010","unstructured":"Fonseca SG, Ishigaki S, Oslowski CM et al (2010) Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 120(3):744\u2013755. https:\/\/doi.org\/10.1172\/JCI39678","journal-title":"J Clin Invest"},{"issue":"11","key":"5905_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/hmg\/ddh125","volume":"13","author":"H Ishihara","year":"2004","unstructured":"Ishihara H, Takeda S, Tamura A et al (2004) Disruption of the WFS1 gene in mice causes progressive \u03b2-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 13(11):1159\u20131170. https:\/\/doi.org\/10.1093\/hmg\/ddh125","journal-title":"Hum Mol Genet"},{"issue":"4","key":"5905_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1152\/physrev.00015.2006","volume":"86","author":"SJ Marciniak","year":"2006","unstructured":"Marciniak SJ, Ron D (2006) Endoplasmic reticulum stress signaling in disease. Physiol Rev 86(4):1133\u20131149. https:\/\/doi.org\/10.1152\/physrev.00015.2006","journal-title":"Physiol Rev"},{"issue":"7","key":"5905_CR10","doi-asserted-by":"publisher","first-page":"e1002511","DOI":"10.1371\/journal.pbio.1002511","volume":"14","author":"M Cagalinec","year":"2016","unstructured":"Cagalinec M, Liiv M, Hodurova Z et al (2016) Role of mitochondrial dynamics in neuronal development: mechanism for Wolfram syndrome. PLoS Biol 14(7):e1002511. https:\/\/doi.org\/10.1371\/journal.pbio.1002511","journal-title":"PLoS Biol"},{"issue":"553","key":"5905_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/scisignal.aaq1380","volume":"11","author":"C Angebault","year":"2018","unstructured":"Angebault C, Fauconnier J, Patergnani S et al (2018) ER-mitochondria cross-talk is regulated by the Ca2+ sensor NCS1 and is impaired in Wolfram syndrome. Sci Signal 11(553):1380. https:\/\/doi.org\/10.1126\/scisignal.aaq1380","journal-title":"Sci Signal"},{"issue":"7","key":"5905_CR12","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/hmg\/ddq568","volume":"20","author":"M Hatanaka","year":"2011","unstructured":"Hatanaka M, Tanabe K, Yanai A et al (2011) Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic \u03b2-cells. Hum Mol Genet 20(7):1274\u20131284. https:\/\/doi.org\/10.1093\/hmg\/ddq568","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5905_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1900\/RDS.2011.8.293","volume":"8","author":"CF Deacon","year":"2011","unstructured":"Deacon CF, Ahren B (2011) Physiology of incretins in health and disease. Rev Diabet Stud 8(3):293\u2013306. https:\/\/doi.org\/10.1900\/RDS.2011.8.293","journal-title":"Rev Diabet Stud"},{"issue":"10","key":"5905_CR14","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","volume":"84","author":"DJ Drucker","year":"1987","unstructured":"Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987) Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84(10):3434\u20133438. https:\/\/doi.org\/10.1073\/pnas.84.10.3434","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"5905_CR15","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.2337\/db09-0685","volume":"58","author":"DA Cunha","year":"2009","unstructured":"Cunha DA, Ladriere L, Ortis F et al (2009) Glucagon-like peptide-1 agonists protect pancreatic \u03b2-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58(12):2851\u20132862. https:\/\/doi.org\/10.2337\/db09-0685","journal-title":"Diabetes"},{"key":"5905_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.addr.2018.07.009","volume":"130","author":"M Yu","year":"2018","unstructured":"Yu M, Benjamin MM, Srinivasan S et al (2018) Battle of GLP-1 delivery technologies. Adv Drug Deliv Rev 130:113\u2013130. https:\/\/doi.org\/10.1016\/j.addr.2018.07.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"5905_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00063030-200822040-00004","volume":"22","author":"T Vilsboll","year":"2008","unstructured":"Vilsboll T, Knop FK (2008) Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus. BioDrugs 22(4):251\u2013257. https:\/\/doi.org\/10.2165\/00063030-200822040-00004","journal-title":"BioDrugs"},{"issue":"1","key":"5905_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db15-0443","volume":"65","author":"C Hernandez","year":"2016","unstructured":"Hernandez C, Bogdanov P, Corraliza L et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 65(1):172\u2013187. https:\/\/doi.org\/10.2337\/db15-0443","journal-title":"Diabetes"},{"key":"5905_CR19","doi-asserted-by":"publisher","first-page":"175439","DOI":"10.1016\/j.ejphar.2022.175439","volume":"938","author":"SD Chen","year":"2023","unstructured":"Chen SD, Chuang YC, Lin TK, Yang JL (2023) Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases. Eur J Pharmacol 938:175439. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175439","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5905_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1185\/03007995.2010.549466","volume":"27","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Burcelin R, Nathanson E (2011) Neuroprotective properties of GLP-1: theoretical and practical applications. Curr Med Res Opin 27(3):547\u2013558. https:\/\/doi.org\/10.1185\/03007995.2010.549466","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"5905_CR21","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","volume":"61","author":"M Kondo","year":"2018","unstructured":"Kondo M, Tanabe K, Amo-Shiinoki K et al (2018) Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia 61(10):2189\u20132201. https:\/\/doi.org\/10.1007\/s00125-018-4679-y","journal-title":"Diabetologia"},{"issue":"1","key":"5905_CR22","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1038\/s41598-018-28314-z","volume":"8","author":"M Toots","year":"2018","unstructured":"Toots M, Seppa K, Jagomae T et al (2018) Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome. Sci Rep 8(1):10183. https:\/\/doi.org\/10.1038\/s41598-018-28314-z","journal-title":"Sci Rep"},{"key":"5905_CR23","doi-asserted-by":"publisher","first-page":"9239530","DOI":"10.1155\/2016\/9239530","volume":"2016","author":"T Sedman","year":"2016","unstructured":"Sedman T, Runkorg K, Krass M et al (2016) Exenatide is an effective antihyperglycaemic agent in a mouse model of Wolfram syndrome 1. J Diabetes Res 2016:9239530. https:\/\/doi.org\/10.1155\/2016\/9239530","journal-title":"J Diabetes Res"},{"issue":"1","key":"5905_CR24","doi-asserted-by":"publisher","first-page":"15742","DOI":"10.1038\/s41598-019-52295-2","volume":"9","author":"K Seppa","year":"2019","unstructured":"Seppa K, Toots M, Reimets R et al (2019) GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome. Sci Rep 9(1):15742. https:\/\/doi.org\/10.1038\/s41598-019-52295-2","journal-title":"Sci Rep"},{"issue":"11","key":"5905_CR25","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.3390\/cells10113193","volume":"10","author":"T Jagomae","year":"2021","unstructured":"Jagomae T, Seppa K, Reimets R et al (2021) Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a wolfram syndrome rat model with an emphasis on visual neurodegeneration, sensorineural hearing loss and diabetic phenotype. Cells 10(11):3193. https:\/\/doi.org\/10.3390\/cells10113193","journal-title":"Cells"},{"issue":"1","key":"5905_CR26","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41598-021-81768-6","volume":"11","author":"K Seppa","year":"2021","unstructured":"Seppa K, Jagomae T, Kukker KG et al (2021) Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model. Sci Rep 11(1):2275. https:\/\/doi.org\/10.1038\/s41598-021-81768-6","journal-title":"Sci Rep"},{"issue":"7397","key":"5905_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/485149a","volume":"485","author":"D Sarewitz","year":"2012","unstructured":"Sarewitz D (2012) Beware the creeping cracks of bias. Nature 485(7397):149. https:\/\/doi.org\/10.1038\/485149a","journal-title":"Nature"},{"issue":"1","key":"5905_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-019-1976-2","volume":"17","author":"CHC Leenaars","year":"2019","unstructured":"Leenaars CHC, Kouwenaar C, Stafleu FR et al (2019) Animal to human translation: a systematic scoping review of reported concordance rates. J Transl Med 17(1):223. https:\/\/doi.org\/10.1186\/s12967-019-1976-2","journal-title":"J Transl Med"},{"issue":"3","key":"5905_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1152\/physiolgenomics.90407.2008","volume":"37","author":"S Koks","year":"2009","unstructured":"Koks S, Soomets U, Paya-Cano JL et al (2009) Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiol Genomics 37(3):249\u2013259. https:\/\/doi.org\/10.1152\/physiolgenomics.90407.2008","journal-title":"Physiol Genomics"},{"issue":"5","key":"5905_CR30","doi-asserted-by":"publisher","first-page":"e0156449","DOI":"10.1371\/journal.pone.0156449","volume":"11","author":"Y Yang","year":"2016","unstructured":"Yang Y, Chen F, Wan D et al (2016) Expression and characterization of a potent long-acting GLP-1 receptor agonist, GLP-1-IgG2sigma-Fc. PLoS One 11(5):e0156449. https:\/\/doi.org\/10.1371\/journal.pone.0156449","journal-title":"PLoS One"},{"issue":"9","key":"5905_CR31","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1172\/JCI58447","volume":"121","author":"P Ravassard","year":"2011","unstructured":"Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121(9):3589\u20133597. https:\/\/doi.org\/10.1172\/JCI58447","journal-title":"J Clin Invest"},{"issue":"6","key":"5905_CR32","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2337\/db08-1510","volume":"58","author":"F Moore","year":"2009","unstructured":"Moore F, Colli ML, Cnop M et al (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-\u03b3-induced pancreatic \u03b2-cell apoptosis. Diabetes 58(6):1283\u20131291. https:\/\/doi.org\/10.2337\/db08-1510","journal-title":"Diabetes"},{"issue":"49","key":"5905_CR33","doi-asserted-by":"publisher","first-page":"E5292","DOI":"10.1073\/pnas.1421055111","volume":"111","author":"S Lu","year":"2014","unstructured":"Lu S, Kanekura K, Hara T et al (2014) A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc Natl Acad Sci U S A 111(49):E5292\u2013E5301. https:\/\/doi.org\/10.1073\/pnas.1421055111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"540","key":"5905_CR34","doi-asserted-by":"publisher","first-page":"9106","DOI":"10.1126\/scitranslmed.aax9106","volume":"12","author":"KG Maxwell","year":"2020","unstructured":"Maxwell KG, Augsornworawat P, Velazco-Cruz L et al (2020) Gene-edited human stem cell-derived \u03b2 cells from a patient with monogenic diabetes reverse preexisting diabetes in mice. Sci Transl Med 12(540):9106. https:\/\/doi.org\/10.1126\/scitranslmed.aax9106","journal-title":"Sci Transl Med"},{"issue":"19","key":"5905_CR35","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1093\/nar\/gky839","volume":"46","author":"C Cosentino","year":"2018","unstructured":"Cosentino C, Toivonen S, Diaz Villamil E et al (2018) Pancreatic \u03b2-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes. Nucleic Acids Res 46(19):10302\u201310318. https:\/\/doi.org\/10.1093\/nar\/gky839","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"5905_CR36","doi-asserted-by":"publisher","first-page":"134221","DOI":"10.1172\/jci.insight.134221","volume":"5","author":"M Igoillo-Esteve","year":"2019","unstructured":"Igoillo-Esteve M, Oliveira AF, Cosentino C et al (2019) Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. JCI Insight 5(2):134221. https:\/\/doi.org\/10.1172\/jci.insight.134221","journal-title":"JCI Insight"},{"issue":"12","key":"5905_CR37","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1172\/JCI141455","volume":"130","author":"E De Franco","year":"2020","unstructured":"De Franco E, Lytrivi M, Ibrahim H et al (2020) YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress. J Clin Invest 130(12):6338\u20136353. https:\/\/doi.org\/10.1172\/JCI141455","journal-title":"J Clin Invest"},{"key":"5905_CR38","doi-asserted-by":"publisher","first-page":"967765","DOI":"10.3389\/fcell.2022.967765","volume":"10","author":"F Fantuzzi","year":"2022","unstructured":"Fantuzzi F, Toivonen S, Schiavo AA et al (2022) In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo. Front Cell Dev Biol 10:967765. https:\/\/doi.org\/10.3389\/fcell.2022.967765","journal-title":"Front Cell Dev Biol"},{"key":"5905_CR39","doi-asserted-by":"publisher","first-page":"56888","DOI":"10.3791\/56888","volume":"130","author":"DB Holmes","year":"2017","unstructured":"Holmes DB, Heine VM (2017) Streamlined 3D cerebellar differentiation protocol with optional 2D modification. J Vis Exp 130:56888. https:\/\/doi.org\/10.3791\/56888","journal-title":"J Vis Exp"},{"issue":"5","key":"5905_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0030-1265163","volume":"119","author":"K Noormets","year":"2011","unstructured":"Noormets K, Koks S, Muldmaa M, Mauring L, Vasar E, Tillmann V (2011) Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp Clin Endocrinol Diabetes 119(5):271\u2013275. https:\/\/doi.org\/10.1055\/s-0030-1265163","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"5905_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","volume":"4","author":"B Yusta","year":"2006","unstructured":"Yusta B, Baggio LL, Estall JL et al (2006) GLP-1 receptor activation improves \u03b2 cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4(5):391\u2013406. https:\/\/doi.org\/10.1016\/j.cmet.2006.10.001","journal-title":"Cell Metab"},{"issue":"13","key":"5905_CR42","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/onc.2011.353","volume":"31","author":"EN Gurzov","year":"2012","unstructured":"Gurzov EN, Barthson J, Marhfour I et al (2012) Pancreatic \u03b2-cells activate a JunB\/ATF3-dependent survival pathway during inflammation. Oncogene 31(13):1723\u20131732. https:\/\/doi.org\/10.1038\/onc.2011.353","journal-title":"Oncogene"},{"issue":"7","key":"5905_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","volume":"40","author":"D Balboa","year":"2022","unstructured":"Balboa D, Barsby T, Lithovius V et al (2022) Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol 40(7):1042\u20131055. https:\/\/doi.org\/10.1038\/s41587-022-01219-z","journal-title":"Nat Biotechnol"},{"issue":"7756","key":"5905_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-019-1168-5","volume":"569","author":"A Veres","year":"2019","unstructured":"Veres A, Faust AL, Bushnell HL et al (2019) Charting cellular identity during human in vitro \u03b2-cell differentiation. Nature 569(7756):368\u2013373. https:\/\/doi.org\/10.1038\/s41586-019-1168-5","journal-title":"Nature"},{"issue":"15","key":"5905_CR45","doi-asserted-by":"publisher","first-page":"145188","DOI":"10.1172\/jci.insight.145188","volume":"6","author":"D Abreu","year":"2021","unstructured":"Abreu D, Stone SI, Pearson TS et al (2021) A phase 1b\/2a clinical trial of dantrolene sodium in patients with Wolfram syndrome. JCI Insight 6(15):145188. https:\/\/doi.org\/10.1172\/jci.insight.145188","journal-title":"JCI Insight"},{"issue":"1","key":"5905_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12967-019-1993-1","volume":"17","author":"MT Pallotta","year":"2019","unstructured":"Pallotta MT, Tascini G, Crispoldi R et al (2019) Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med 17(1):238. https:\/\/doi.org\/10.1186\/s12967-019-1993-1","journal-title":"J Transl Med"},{"key":"5905_CR47","doi-asserted-by":"publisher","first-page":"768023","DOI":"10.3389\/fphar.2021.768023","volume":"12","author":"S Shah","year":"2021","unstructured":"Shah S, Dooms MM, Amaral-Garcia S, Igoillo-Esteve M (2021) Current drug repurposing strategies for rare neurodegenerative disorders. Front Pharmacol 12:768023. https:\/\/doi.org\/10.3389\/fphar.2021.768023","journal-title":"Front Pharmacol"},{"key":"5905_CR48","doi-asserted-by":"publisher","first-page":"111529","DOI":"10.1016\/j.mce.2021.111529","volume":"542","author":"M Zhang","year":"2022","unstructured":"Zhang M, Wu Y, Gao R, Chen X, Chen R, Chen Z (2022) Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer\u2019s disease by suppressing NLRP2 activation in astrocytes. Mol Cell Endocrinol 542:111529. https:\/\/doi.org\/10.1016\/j.mce.2021.111529","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"5905_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000510852","volume":"93","author":"KJ Scully","year":"2020","unstructured":"Scully KJ, Wolfsdorf JI (2020) Efficacy of GLP-1 agonist therapy in autosomal dominant WFS1-related disorder: a case report. Horm Res Paediatr 93(6):409\u2013414. https:\/\/doi.org\/10.1159\/000510852","journal-title":"Horm Res Paediatr"},{"key":"5905_CR50","doi-asserted-by":"publisher","first-page":"755365","DOI":"10.3389\/fped.2021.755365","volume":"9","author":"G Frontino","year":"2021","unstructured":"Frontino G, Raouf T, Canarutto D et al (2021) Case report: off-label liraglutide use in children with Wolfram syndrome type 1: extensive characterization of four patients. Front Pediatr 9:755365. https:\/\/doi.org\/10.3389\/fped.2021.755365","journal-title":"Front Pediatr"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05905-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-05905-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05905-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T14:03:24Z","timestamp":1686060204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-05905-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5905"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-05905-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"1 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}